Chlorhexidine and silver-sulfadiazine coated central venous catheters in haematological patients—a double-blind, randomised, prospective, controlled trial

• Verfasst von: Ostendorf, Torben Armin [VerfasserIn]
• Verfasst von: Meinhold, Andrea [VerfasserIn]
• Verfasst von: Harter, Christoph [VerfasserIn]
• Verfasst von: Salwender, Hans [VerfasserIn]
• Verfasst von: Egerer, Gerlinde [VerfasserIn]
• Verfasst von: Geiss, Heinrich K. [VerfasserIn]
• Verfasst von: Ho, Anthony Dick [VerfasserIn]
• Verfasst von: Goldschmidt, Hartmut [VerfasserIn]
• Titel: Chlorhexidine and silver-sulfadiazine coated central venous catheters in haematological patients—a double-blind, randomised, prospective, controlled trial
• Verf.angabe: Torben Ostendorf, Andrea Meinhold, Christoph Harter, Hans Salwender, Gerlinde Egerer, Heinrich K. Geiss, Antony D. Ho, Hartmut Goldschmidt
• E-Jahr: 2005
• Jahr: 16 April 2005
• Umfang: 8 S.
• Illustrationen: Illustrationen
• Fussnoten: Gesehen am 25.02.2022
• Titel Quelle: Enthalten in: Supportive care in cancer
• Ort Quelle: Berlin : Springer, 1993
• Jahr Quelle: 2005
• Band/Heft Quelle: 13(2005), 12 vom: Apr., Seite 993-1000
• ISSN Quelle: 1433-7339
• DOI: doi:10.1007/s00520-005-0812-9
• Datenträger: Online-Ressource
• Sprache: eng
• K10plus-PPN: 1793891362

Abstract

Central venous catheters (CVCs) are essential for the intensive care of patients with haematological illness. Catheter-related infections (CRI) are an important problem in modern medicine, which may lead to life-threatening situations, to prolonged hospitalisation and increased cost. In immunocompromised patients suffering from haemato-oncological diseases, CRI is a significant factor for adverse outcome. Several clinical studies have shown that CVCs coated with antiseptics such as chlorhexidine and silver-sulfadiazine (CHSS) reduce the risk of catheter-related bacteraemia. Most studies, however, were performed on intensive care patients not suffering from chemotherapy-induced immunosuppression.